Development of a Syrian Hamster anti-PD-L1 monoclonal antibody enables adenoviral oncolytic immunotherapy modelling in an immunocompetent virus replication permissive setting.

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Clubb J., Kudling T.V., Quixabeira D., Santos J., Havunen R., Heiniö C., Cervera-Carrascon V., Pakola S., Basnet S., Grönberg-Vähä-Koskela s., Kanerva A., & Hemminki A.

Journal title: Frontiers in Immunology

Journal number: vol.14

Journal publisher: Frontiers

Published year: 2023

DOI identifier: 10.3389/fimmu.2023.1060540

ISSN: 1664-3224